Short Interest in Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Drops By 66.7%

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 200 shares, a decline of 66.7% from the December 15th total of 600 shares. Based on an average daily volume of 800 shares, the days-to-cover ratio is currently 0.3 days.

Mosaic ImmunoEngineering Stock Performance

Shares of Mosaic ImmunoEngineering stock traded down $0.03 during midday trading on Tuesday, hitting $0.94. 297 shares of the company traded hands, compared to its average volume of 1,600. The stock has a market cap of $6.81 million, a price-to-earnings ratio of -6.27 and a beta of 0.27. The firm’s fifty day moving average price is $0.89 and its 200-day moving average price is $0.85. Mosaic ImmunoEngineering has a 12 month low of $0.10 and a 12 month high of $1.13.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.